AB 306

This bill requires the implementation of an electronic system for recording,

tracking, and blocking the illegal sale of pseudoephedrine products and makes

certain other changes to the pseudoephedrine sale process.

Current law requires that sellers of pseudoephedrine products record the name

and address of the purchaser and the name and quantity of the pseudoephedrine

product being sold in either paper or electronic format, and requires the purchaser

to present an identification card containing the purchaser's photograph. At the time

of sale, both the seller, or a pharmacist supervising the seller, and the purchaser

must also sign a record of the transaction. Under the bill, the purchaser must present

an identification card containing the purchaser's photograph, and the seller must

record the identification type and, if applicable, the identification number, and the

date and time of the sale, in addition to the information that is currently gathered,

and all records must be kept in electronic format.

Under the bill, prior to completing a pseudoephedrine sale, the seller must

electronically submit the sale information to the National Precursor Log Exchange,

which is a real-time electronic tracking system that is available at no cost to the

sellers. The system uses the information to generate a real-time notification, called

a stop sale alert, that notifies the seller if completing the sale would cause the

purchaser to be in violation of the quantity limits currently in place on

nonprescription pseudoephedrine purchases. The system will contain an override

function that the seller may use in emergencies, the use of which is recorded by the

system. The system must provide real-time access to the records for law

enforcement purposes. The tracking requirements do not apply to pseudoephedrine

sales pursuant to a valid prescription.